T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$3.3B |
| 2 |
Eli Lilly
LLY
|
+$2.75B |
| 3 |
AstraZeneca
AZN
|
+$1.98B |
| 4 |
Coupang
CPNG
|
+$1.54B |
| 5 |
Fortinet
FTNT
|
+$1.48B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$2.34B |
| 2 |
Morgan Stanley
MS
|
+$2.26B |
| 3 |
Airbnb
ABNB
|
+$2.04B |
| 4 |
Qualcomm
QCOM
|
+$1.95B |
| 5 |
NVIDIA
NVDA
|
+$1.81B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.35% |
| 2 | Healthcare | 16.19% |
| 3 | Consumer Discretionary | 15.55% |
| 4 | Financials | 12.84% |
| 5 | Communication Services | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Acadia Healthcare
ACHC
$2.95B
| $616M | 0.06% |
10,782,501
+450,307
| +4% | +$24.4M |
|
302
AvalonBay Communities
AVB
$25.7B
| $606M | 0.06% |
3,282,494
-40,527
| -1% | -$7.09M |
|
303
EQT Corp
EQT
$33.8B
| $599M | 0.06% |
32,217,017
+435,133
| +1% | +$7.57M |
|
304
Cardinal Health
CAH
$54.5B
| $586M | 0.06% |
9,646,259
+640,591
| +7% | +$35.4M |
|
305
Lowe's Companies
LOW
$121B
| $585M | 0.06% |
3,075,093
+973,815
| +46% | +$167M |
|
306
Crown Castle
CCI
$31.5B
| $583M | 0.06% |
3,387,835
-324,423
| -9% | -$52M |
|
307
Freeport-McMoran
FCX
$96.9B
| $576M | 0.06% |
17,487,028
-17,491,635
| -50% | -$567M |
|
308
Ionis Pharmaceuticals
IONS
$9.39B
| $566M | 0.06% |
12,580,056
-534,911
| -4% | -$29.8M |
|
309
Array Technologies
ARRY
$799M
| $565M | 0.06% |
18,946,859
+1,458,059
| +8% | +$58.2M |
|
310
Neurocrine Biosciences
NBIX
$15.9B
| $561M | 0.06% |
5,773,359
-498,371
| -8% | -$52.3M |
|
311
GSK
GSK
$101B
| $555M | 0.06% |
12,434,625
-807,069
| -6% | -$36.6M |
|
312
Willis Towers Watson
WTW
$31.6B
| $543M | 0.05% |
2,370,331
-1,180,345
| -33% | -$257M |
|
|
PRAH
313
DELISTED
PRA Health Sciences, Inc.
PRAH
| $542M | 0.05% |
3,533,621
-3,521,239
| -50% | -$478M |
|
314
SiteOne Landscape Supply
SITE
$4.22B
| $542M | 0.05% |
3,172,066
-114,585
| -3% | -$19M |
|
315
FirstEnergy
FE
$27.2B
| $540M | 0.05% |
15,559,701
+816,264
| +6% | +$26.7M |
|
316
VeriSign
VRSN
$25.6B
| $539M | 0.05% |
2,711,586
+688,880
| +34% | +$135M |
|
317
Raymond James Financial
RJF
$34.9B
| $539M | 0.05% |
6,594,069
-939,264
| -12% | -$70M |
|
|
PPD
318
DELISTED
PPD, Inc. Common Stock
PPD
| $534M | 0.05% |
14,100,789
+1,068,055
| +8% | +$38.3M |
|
319
Armstrong World Industries
AWI
$7.75B
| $533M | 0.05% |
5,920,413
-913,626
| -13% | -$77.6M |
|
|
THS
320
DELISTED
Treehouse Foods
THS
| $533M | 0.05% |
10,198,228
+58,895
| +0.6% | +$2.79M |
|
321
Alaska Air
ALK
$5.29B
| $532M | 0.05% |
7,682,219
-1,481,271
| -16% | -$89M |
|
322
MongoDB
MDB
$35.2B
| $530M | 0.05% |
1,980,429
-125,058
| -6% | -$44.3M |
|
323
ICU Medical
ICUI
$4.48B
| $530M | 0.05% |
2,577,820
-62,544
| -2% | -$13.2M |
|
324
AXIS Capital
AXS
$7.26B
| $526M | 0.05% |
10,609,389
-73,166
| -0.7% | -$3.67M |
|
325
Imperial Oil
IMO
$63.1B
| $525M | 0.05% |
21,732,102
-2,362,180
| -10% | -$52.1M |
|
Similar funds
T. Rowe Price Associates's Q1 2021 Portfolio in Review
As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
- T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
- T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
- T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
- T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
- T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.